CSI Market
Sign In | Register

Engene Therapeutics Inc (ENGN) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ENGN Annual Balance Sheets →
This page allows investors to track Engene Therapeutics Inc's balance sheet development across multiple reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jul 31 2026)
(Apr 30 2026) (Jan 31 2026) (Oct 31 2025) (Jul 31 2025)
Assets
Cash & cash equivalent41.03
Marketable Securities, Current SH225.30
Cash & Short-term Investments266.00
Other Current Assets0.98
Prepaid Expense And Other Assets Current10.53
Total Current Assets277.90
Equipment/Property/Plant Net4.79
Long-term investments0.08
Other Assets, Noncurrent5.55
Investment Tax Credits Receivable0.82
Total Assets288.32
Liabilities
Accounts Payable, Current AC2.54
Accrued Liabilities And Other Liabilities7.10
Notes Payable, Current NO0.20
Other Liabilities, Current17.37
Total Current Liabilities27.21
Long-term debt25.16
Total Long-term Debt25.16
Other liabilities, Noncurrent5.67
Operating Lease Liability Current2.29
Total Liabilities58.03
Stockholders' Equity
Common Stock Value632.02
Additional Paid In Capital Common Stock64.13
Retained Earnings / Accumulated Deficit-464.51
Accumulated Other Comprehensive Income-1.35
Other Equity-1.35
Common Stockholder's Equity230.29
Total Stockholder's Equity230.29
Liabilities & Stockholder's Equity288.32
4 historic quarters locked

Sign in to unlock the full Engene Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Engene Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260731)
  • Filed with the SEC: September 8, 2026
  • Source: engn-20260731.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-384383

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.